30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Bionik Laboratories Corp (BNKL)

Stock chart
Ticker: BNKL Exchange: OTC


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Gaston-Dreyfus Remi
1 purchase — total 108,333 USD
Buy 9 Jun 2023
Value US$2,238,917.23 | Price 326.58 | Shares 55,453
Buy 9 Jun 2023
Value US$649,353.76 | Price 384.75 | Shares 24,811
Buy 9 Jun 2023
Value US$390,000.00 | Price 0.60 | Shares 650,000
Buy 26 Mar 2021
Value US$0.00 | Price 0.00 | Shares 135,560
Buy 26 Mar 2021
Value US$0.00 | Price 0.00 | Shares 95,149
Buy 26 Aug 2019
Value US$399,906.08 | Price 3.76 | Shares 106,358
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-06-21 2023-06-09 B Purchase Non-Executive Director Large shareholder
55,453 +49.2%
326.58
US$2,238,917
55,453 +49.2% 326.58 US$2,238,917
2023-06-21 2023-06-09 B Purchase Non-Executive Director
24,811 -26.0%
384.75
US$649,354
24,811 -26.0% 384.75 US$649,354
2023-06-21 2023-06-09 B Purchase Non-Executive Director
80,665 -44.8%
46.92
US$1,394,433
80,665 -44.8% 46.92 US$1,394,433
2021-12-13 2021-03-26 B Purchase Non-Executive Director Large shareholder
135,560
0.00
US$0
135,560 0.00 US$0
2021-04-01 2021-03-26 B Purchase

Chairman

Executive Director
95,149
0.00
US$0
95,149 0.00 US$0
2019-08-28 2019-08-26 B Purchase Gaston-Dreyfus Remi Non-Executive Director Large shareholder
106,358 +9.7%
3.76
US$399,906
106,358 +9.7% 3.76 US$399,906